The principal cancer research agency of the U.S. government, part of the NIH, funding and leading research on cancer prevention, detection, and care.
BERT-style language model for somatic mutations, pretrained on cancer sequencing from 210,000+ patients for tumor subtyping and therapy response.
National Cancer Institute / Australian National University / Sungkyunkwan University / University of Pennsylvania / Cedars-Sinai Medical Center
Released February 28, 2025
Histopathology model predicting gene expression and DNA methylation from H&E slides across 23 cancer types, fusing FFPE and fresh-frozen predictors.
National Cancer Institute / University of Illinois Urbana-Champaign / Sanford Burnham Prebys / National Institute on Aging / Marble Therapeutics
Released November 15, 2024
Single-cell transcriptomic aging clock predicting immune age for CD8+, CD4+ T and NK cells, and transferring to bulk whole-blood RNA-seq.
Sanford Burnham Prebys / Rady Children's Institute for Genomic Medicine / National Cancer Institute / University of California, San Diego / Rady Children's Hospital-San Diego / Leibniz University Hannover
Released November 15, 2024
Histopathology model predicting extrachromosomal DNA status from routine H&E slides by first inferring the tumor transcriptome from tile features.
National Cancer Institute / Cedars-Sinai Medical Center / University of Cambridge / The Institute of Cancer Research, London / University of Pennsylvania / University of Sydney / Sungkyunkwan University / University of Maryland, College Park / Medical University of Graz / Tel Aviv University / Hebrew University of Jerusalem
Released October 18, 2024
Spatial transcriptomics prediction from H&E slides, inferring spot-level expression and tumor microenvironment composition in breast cancer.